Invitae Corp
NVTADelisted- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001501134
Invitae Corp was delisted in 2024; its insiders filed their last Form 4 on Dec 21, 2023; 204 institutions reported holding it in 13F filings for Q4 2023, worth $100.6M in total; ARK Invest was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Invitae Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Invitae Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Nussbaum Robert L | Chief Medical Officer | 551,941 | Dec 21, 2023 | 0 |
| Brida Thomas | See Remarks | 916,183 | Dec 21, 2023 | 0 |
| Sholehvar David | Chief Operating Officer | 850,000 | Nov 14, 2023 | 0 |
| Schrank Ana J. | Chief Financial Officer | 850,000 | Oct 2, 2023 | 0 |
| Guigley Robert M. | Chief Commercial Officer | 850,000 | Sep 25, 2023 | 0 |
| Wen Yafei | Chief Financial Officer | 700,297 | May 24, 2023 | 0 |
| Werner Robert F. | Chief Accounting Officer | 354,748 | May 18, 2023 | 0 |
| Knight Kenneth D. | Chief Executive Officer | 1,671,610 | May 18, 2023 | 0 |
| Aguiar Eric | Director | 125,322 | May 1, 2023 | 0 |
| Scott Randal W. | Director | 161,222 | May 1, 2023 | 0 |
| Gorjanc Christine Marie | Director | 111,022 | May 1, 2023 | 0 |
| Osborne William H | Director | 158,450 | May 1, 2023 | 0 |
| Crouse Geoffrey | Director | 130,281 | May 1, 2023 | 0 |
| Nayak Chitra | Director | 111,022 | May 1, 2023 | 0 |
| Lockhart Kimber D | Director | 111,022 | May 1, 2023 | 0 |
| George Sean E | Director | 732,677 | Dec 20, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2023 (view filing) | Jun 13 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −7.09K | $1.38 | −$9.78K | −1.2%569.3K after | |
| Jun 15, 2023 (view filing) | Jun 13 | 2 days | Brida ThomasSee Remarks | SSale | −7.08K | $1.38 | −$9.77K | −1.0%704.1K after | |
| May 24, 2023 (view filing) | May 16 | 8 days | Wen YafeiChief Financial Officer | SSale | −43.5K | $1.20 | −$52.1K | −5.8%700.3K after | Amended |
| May 18, 2023 (view filing) | May 16 | 2 days | Knight Kenneth D.Chief Executive Officer | SSale | −45.4K | $1.20 | −$54.5K | −2.6%1.67M after | |
| May 18, 2023 (view filing) | May 16 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −26.5K | $1.20 | −$31.8K | −4.4%576.4K after | |
| May 18, 2023 (view filing) | May 16 | 2 days | Werner Robert F.Chief Accounting Officer | SSale | −21.6K | $1.20 | −$25.9K | −5.7%354.7K after | |
| May 18, 2023 (view filing) | May 16 | 2 days | Brida ThomasSee Remarks | SSale | −26.5K | $1.20 | −$31.8K | −3.6%711.2K after | |
| Mar 15, 2023 (view filing) | Mar 13 | 2 days | Brida ThomasSee Remarks | SSale | −2.63K | $1.41 | −$3.70K | −0.6%437.6K after | |
| Mar 15, 2023 (view filing) | Mar 13 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −2.63K | $1.41 | −$3.70K | −0.6%447.9K after | |
| Mar 15, 2023 (view filing) | Mar 13 | 2 days | Wen YafeiChief Financial Officer | SSale | −2.63K | $1.41 | −$3.70K | −0.6%443.7K after | |
| Mar 15, 2023 (view filing) | Mar 13 | 2 days | Knight Kenneth D.Chief Executive Officer | SSale | −1.85K | $1.41 | −$2.61K | −0.4%517.0K after | |
| Dec 20, 2022 (view filing) | Dec 16-19 | 4 days | George Sean EDirector | SSale | −56.0K | $2.05 | −$114.6K | −7.1%732.7K after | 2 lots |
| Aug 29, 2022 (view filing) | Aug 25 | 4 days | Werner Robert F.Chief Accounting Officer | SSale | −1.35K | $3.45 | −$4.66K | −0.5%251.3K after | |
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Brida ThomasSee remarks | SSale | −7.05K | $4.55 | −$32.1K | −1.8%386.3K after | |
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −7.05K | $4.55 | −$32.1K | −1.7%396.5K after | |
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | George Sean EDirector | SSale | −22.1K | $4.55 | −$100.5K | −2.7%788.7K after | |
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Werner Robert F.Chief Accounting Officer | SSale | −3.25K | $4.55 | −$14.8K | −1.6%198.7K after | |
| May 19, 2022 (view filing) | May 17-19 | 2 days | Werner Robert F.Chief Accounting Officer | SSale | −10.1K | $3.70 | −$37.4K | −4.8%201.9K after | 2 lots |
| May 19, 2022 (view filing) | May 17 | 2 days | Knight Kenneth D.Chief Operating Officer | SSale | −28.3K | $3.81 | −$107.8K | −5.2%518.9K after | |
| May 19, 2022 (view filing) | May 17 | 2 days | Brida ThomasSee Remarks | SSale | −6.10K | $3.81 | −$23.2K | −1.5%393.3K after | |
| May 19, 2022 (view filing) | May 17 | 2 days | George Sean EPresident & CEO | SSale | −18.3K | $3.81 | −$69.7K | −2.3%794.7K after | |
| May 19, 2022 (view filing) | May 17 | 2 days | Wen YafeiChief Financial Officer | SSale | −17.0K | $3.81 | −$64.9K | −4.7%344.4K after | |
| May 19, 2022 (view filing) | May 17 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −6.10K | $3.81 | −$23.2K | −1.5%403.6K after | |
| Mar 21, 2022 (view filing) | Mar 14 | 7 daysLate | Knight Kenneth D.Chief Operating Officer | SSale | −2.36K | $6.69 | −$15.8K | −0.7%322.2K after | |
| Mar 16, 2022 (view filing) | Mar 14 | 2 days | George Sean EPresident & CEO | SSale | −31.4K | $6.69 | −$210.0K | −3.7%813.0K after | |
| Mar 16, 2022 (view filing) | Mar 14 | 2 days | Brida ThomasGeneral Counsel | SSale | −18.0K | $6.69 | −$120.3K | −7.3%229.7K after | |
| Mar 16, 2022 (view filing) | Mar 14 | 2 days | Wen YafeiChief Financial Officer | SSale | −3.29K | $6.69 | −$22.0K | −2.4%136.4K after | |
| Mar 16, 2022 (view filing) | Mar 14 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −19.6K | $6.69 | −$131.0K | −7.5%241.2K after | |
| Nov 15, 2021 (view filing) | Nov 11 | 4 days | Nussbaum Robert LChief Medical Officer | SSale | −29.7K | $21.89 | −$649.6K | −10.8%246.1K after | |
| Oct 26, 2021 (view filing) | Oct 22 | 4 days | George Sean EPresident & CEO | SSale | −3.67K | $28.06 | −$103.1K | −0.5%800.3K after | |
| Sep 24, 2021 (view filing) | Sep 22 | 2 days | George Sean EPresident & CEO | SSale | −7.35K | $31.88 | −$234.3K | −1.0%748.9K after | |
| Aug 20, 2021 (view filing) | Aug 19 | 1 day | Werner Robert F.Chief Accounting Officer | SSale | −15.3K | $24.86 | −$381.3K | −17.2%74.0K after | |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Nussbaum Robert LChief Medical Officer | SSale | −21.2K | $25.42 | −$539.7K | −7.9%246.1K after | |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Brida ThomasGeneral Counsel | SSale | −14.4K | $25.42 | −$367.0K | −5.8%232.5K after | |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | George Sean EPresident & CEO | SSale | −17.0K | $25.42 | −$431.8K | −2.2%756.3K after | |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Werner Robert F.Chief Accounting Officer | SSale | −3.01K | $25.42 | −$76.6K | −3.3%89.3K after | |
| Jul 23, 2021 (view filing) | Jul 22 | 1 day | George Sean EPresident & CEO | SSale | −3.67K | $29.39 | −$108.0K | −0.5%773.3K after |